Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

Go back to Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
Beam Inc. (NASDAQ: BEAM) Delayed: 35.53 --0 (-0%)
Previous Close $35.53    52 Week High $83.60 
Open $35.53    52 Week Low $82.96 
Day High $35.53    P/E 15.86 
Day Low $35.53    EPS $2.24 
Volume 25,924